Return to Provider News

Preauthorization Update Effective February 1, 2023, for All Lines of Business Requiring Preauthorization

Audience: All Participating Providers

We would like to advise you of updates to preauthorization requirements under our Utilization Management (UM) Program.

The UM Program gives Univera Healthcare and its provider partners the opportunity to monitor medical episodes of care to prevent unnecessary treatment and duplication of services. The UM Program manages a subset of select services to ensure medically necessary care is provided.

Preauthorization is required for all services listed on our preauthorization list for member contracts requiring preauthorization, regardless of the place of service (i.e., office, inpatient, or outpatient setting). Please keep in mind that failure to follow UM policies and procedures, including failure to obtain preauthorization when required and, failure to comply with your provider agreement or our member contract requirements, may result in claim denial or reduction in payment.

For details on preauthorization updates effective February 1, 2023, please refer to the document available here.

Each preauthorization update, effective February 1, 2023, will be highlighted in gray.

This update includes the addition of E0485, which pertains to dental services.
Important note: Codes may be added throughout the year as released by the American Medical Association and Centers for Medicare & Medicaid Services. Releases may not coincide with quarterly notifications to providers.

Courtesy Preauthorization

Courtesy preauthorization is available, at our discretion, for select services and product lines.

InterQual® Updates

We will update InterQual® information on our website when it becomes available. You will receive advance written notice regarding the effective date of any InterQual updates or revisions.

Medical Necessity Audits

As we update our UM programs, we will implement additional retrospective reviews as needed using medical necessity post-service reviews or medical necessity audit(s), in lieu of preauthorization. Please be aware that these audits or reviews may be conducted post-service prior to payment or post-payment. As part of the UM retrospective review program, we will implement select medical necessity audits throughout 2022 and will provide notice of any additional details. We are mindful of the impacts to our providers as we strive to manage medical expense to meet our responsibility to our members and employer groups.

Durable Medical Equipment (DME)

Claims will deny or suspend for medical necessity review across all lines of business if preauthorization for applicable DME is not obtained. The current list of DME requiring preauthorization is available here.

Medicare Line of Business

We follow the CMS coverage guidelines for our Medicare Advantage line of business. These policies are located at

Refer to  To view the list of approved facilities for these procedures, visit

Thank you for your continued partnership in the care of our members.

Related News
CareAdvance Authorization Request – Requesting Provider Requirements

Prior Authorization Updates for Elitek®, Abraxane® & Paclitaxel Protein- Bound Particles, Neulasta® and Udenyca® Effective March 1, 2023

Prior Authorization Update for Neulasta® and Udenyca® (pegfilgrastim) Effective March 1, 2023

Medicare Advantage Prior Authorization for Select Oncology Medications



Utilization Management


GDPR Notification Content